{
  "ticker": "ABBV",
  "year": 2026,
  "quarter": 1,
  "last_updated": "2026-02-21T08:41:42.682531",
  "count": 9,
  "transactions": [
    {
      "id": 631,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Crum Demetris D",
      "reporting_owner_cik": "0002078592",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2026-02-18",
      "transaction_shares": "1216",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8264"
    },
    {
      "id": 632,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2026-02-18",
      "transaction_shares": "33833",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "166654"
    },
    {
      "id": 633,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Purdue David Ryan",
      "reporting_owner_cik": "0002057696",
      "reporting_owner_position": "SVP, Controller",
      "transaction_date": "2026-02-18",
      "transaction_shares": "2505",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7010"
    },
    {
      "id": 634,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2026-02-18",
      "transaction_shares": "26063",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "79297"
    },
    {
      "id": 635,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2026-02-18",
      "transaction_shares": "16290",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "20909"
    },
    {
      "id": 636,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "EVP, R&D and CSO",
      "transaction_date": "2026-02-18",
      "transaction_shares": "6015",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "48291"
    },
    {
      "id": 637,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2026-02-18",
      "transaction_shares": "13031",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "71278"
    },
    {
      "id": 638,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2026-02-18",
      "transaction_shares": "17041",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "194333"
    },
    {
      "id": 639,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2026-02-18",
      "transaction_shares": "25062",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36639"
    }
  ]
}